Veronica Steri

2.9k total citations · 2 hit papers
34 papers, 1.8k citations indexed

About

Veronica Steri is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Veronica Steri has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Veronica Steri's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Veronica Steri is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (7 papers) and HER2/EGFR in Cancer Research (5 papers). Veronica Steri collaborates with scholars based in United States, United Kingdom and Switzerland. Veronica Steri's co-authors include Gabriele Bergers, Arnaud Jabouille, Iacovos P. Michael, Douglas Hanahan, Elizabeth Allen, Lee B. Rivera, Rindert Missiaen, Inge Lodewijckx, Byron Hann and Mark M. Moasser and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Veronica Steri

32 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

2017 589 citations Elizabeth Allen, Arnaud Jabouille et al. Science Translational Medicine profile →
Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins

2022 152 citations Katarina Pance, Josef A. Gramespacher et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veronica Steri United States	17	827	796	705	215	205	34	1.8k
Steffen Rickelt United States	21	780 0.9×	675 0.8×	412 0.6×	200 0.9×	138 0.7×	47	1.7k
Malin Pedersen United Kingdom	22	1.1k 1.3×	1.3k 1.6×	673 1.0×	293 1.4×	267 1.3×	37	2.4k
Sachi Horibata United States	16	477 0.6×	838 1.1×	550 0.8×	281 1.3×	123 0.6×	31	1.6k
Elisabeth J. M. Huijbers Netherlands	19	486 0.6×	697 0.9×	432 0.6×	347 1.6×	146 0.7×	35	1.3k
Mark B. Meads United States	12	753 0.9×	771 1.0×	307 0.4×	307 1.4×	129 0.6×	36	1.6k
Viia Valge-Archer United Kingdom	19	1.0k 1.2×	1.1k 1.4×	1.2k 1.7×	373 1.7×	130 0.6×	27	2.4k
Markus Münz Germany	12	1.0k 1.3×	1.0k 1.3×	330 0.5×	372 1.7×	131 0.6×	18	1.9k
Rajasekharan Somasundaram United States	26	878 1.1×	869 1.1×	1.1k 1.6×	181 0.8×	115 0.6×	76	1.9k
Sandra Coral Italy	25	691 0.8×	1.6k 1.9×	1.1k 1.5×	270 1.3×	195 1.0×	53	2.3k

Countries citing papers authored by Veronica Steri

Since Specialization

Citations

This map shows the geographic impact of Veronica Steri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Steri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Steri more than expected).

Fields of papers citing papers by Veronica Steri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Steri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Steri. The network helps show where Veronica Steri may publish in the future.

Co-authorship network of co-authors of Veronica Steri

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Steri. A scholar is included among the top collaborators of Veronica Steri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Steri. Veronica Steri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Xiaoxiao, et al.. (2024). Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR - and KRAS -Mutant Lung Cancer. Cancer Research Communications. 5(1). 119–127.

Glasgow, Jeff E., Rita P. Loudermilk, Lisa L. Kirkemo, et al.. (2024). Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α. Cell chemical biology. 31(9). 1729–1739.e9. 2 indexed citations

Coppé, Jean‐Philippe, Denise P. Muñoz, Chloé E. Atreya, et al.. (2024). Abstract 4735: Targeting CDK1/2-driven mechanisms of resistance to BRAF and EGFR inhibition in BRAF(V600E) colorectal cancer restores therapeutic response. Cancer Research. 84(6_Supplement). 4735–4735. 1 indexed citations

Nix, Matthew A., Huimin Geng, Rebecca C. Larson, et al.. (2023). Affinity Matured CD72 CAR-T Improves Efficacy Versus Low Antigen Density B-Cell Non-Hodgkin Lymphoma Models. Blood. 142(Supplement 1). 2068–2068. 1 indexed citations

Popescu, Bogdan, Carlos Stahlhut, Bianca J. Lee, et al.. (2023). Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. Cell Reports Medicine. 4(11). 101290–101290. 6 indexed citations

Nix, Matthew A., Benjamin J. Huang, Juan A. Cámara, et al.. (2023). Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies. Journal for ImmunoTherapy of Cancer. 11(11). e006985–e006985. 14 indexed citations

Lim, Shion A., Jie Zhou, Alexander J. Martinko, et al.. (2022). Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers. Journal of Clinical Investigation. 132(4). 21 indexed citations

Caravaca, J., et al.. (2022). Comparison and calibration of dose delivered by ¹³⁷Cs and x-ray irradiators in mice. Physics in Medicine and Biology. 67(22). 225017–225017.

Campbell, Marcia R., Ana Ruiz-Sáenz, Christopher Agnew, et al.. (2022). Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers. Cell Reports. 38(5). 110291–110291. 15 indexed citations

10.

Zhang, Ziyang, Chayanid Ongpipattanakul, Koli Basu, et al.. (2022). A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy. Cancer Cell. 40(9). 1060–1069.e7. 86 indexed citations

11.

Pance, Katarina, Josef A. Gramespacher, James R. Byrnes, et al.. (2022). Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. Nature Biotechnology. 41(2). 273–281. 152 indexed citations breakdown →

12.

Melnyk, James E., Veronica Steri, Hao G. Nguyen, et al.. (2022). Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. Oncogene. 41(11). 1536–1549. 9 indexed citations

13.

Campbell, Marcia R., Ana Ruiz-Sáenz, Yuntian Zhang, et al.. (2022). Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling. Cell Reports. 38(5). 110285–110285. 13 indexed citations

14.

Majumder, Avisek, Manbir Sandhu, Debarko Banerji, et al.. (2021). The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. Scientific Reports. 11(1). 9091–9091. 35 indexed citations

15.

Elledge, Susanna K., Hai L. Tran, Alec H. Christian, et al.. (2020). Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation. Proceedings of the National Academy of Sciences. 117(11). 5733–5740. 40 indexed citations

16.

Melnyk, James E., Veronica Steri, Hao G. Nguyen, et al.. (2020). The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells. Bioorganic & Medicinal Chemistry. 28(20). 115712–115712. 18 indexed citations

17.

He, Bo, Arnaud Jabouille, Veronica Steri, et al.. (2018). Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. The Journal of Pathology. 245(2). 209–221. 84 indexed citations

18.

Allen, Elizabeth, Arnaud Jabouille, Lee B. Rivera, et al.. (2017). Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation. Science Translational Medicine. 9(385). 589 indexed citations breakdown →

19.

Steri, Veronica, Katherine N. Weilbaecher, Jochen G. Schneider, et al.. (2013). Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice. Circulation Research. 114(1). 79–91. 30 indexed citations

20.

Faure-André, Gabrielle, Pablo Vargas, María-Isabel Yuseff, et al.. (2008). Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant Chain. Science. 322(5908). 1705–1710. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact